Esports Technologies Inc. (EBET) News
Filter EBET News Items
EBET News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest EBET News From Around the Web
Below are the latest news stories about EBET INC that investors may wish to consider to help them evaluate EBET as an investment opportunity.
WestPark Capital Announces Closing of $6.5 Million Registered Direct Offering Priced At-The-Market for Ebet Inc. (NASDAQ:EBET)LOS ANGELES, February 14, 2023--WestPark Capital, a Los Angeles based international investment bank and securities firm, announced today that it closed a registered direct offering of 6,372,530 shares (the "Shares") of common stock, and a concurrent private placement of warrants to purchase 6,372,530 shares (the "Warrant Shares") of common stock (the "Warrants") at a combined purchase price of $1.02 priced at-the-market under Nasdaq rules for EBET, a global provider of advanced wagering products |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday! |
Why Is EBET (EBET) Stock Up 25% Today?EBET (EBET) stock is taking off on Monday as heavy trading pushes the sports betting company's shares higher following the Super Bowl. |
Why Is G1 Therapeutics (GTHX) Stock Down 52% Today?G1 Therapeutics (GTHX) stock is falling on Monday after the company announced plans to discontinue a Phase 3 clinical trial. |
Why Is Sorrento Therapeutics (SRNE) Stock Down 40% Today?Sorrento Therapeutics (SRNE) stock is falling on Monday after the company filed for bankruptcy alongside Scintilla Pharmaceuticals. |
Why Is Vallon Pharmaceuticals (VLON) Stock Up 38% TodayVallon Pharmaceuticals (VLON) stock is rising higher on Monday despite a lack of news from the clinical-stage biopharmaceutical company. |
EBET Announces Closing of Approximately $6.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesEBET, Inc. (NASDAQ:EBET), a leading global provider of advanced wagering products and technology, announced today that it closed its previously announced registered direct offering of 6,372,530 shares (the "Shares") of common stock, and a concurrent private placement of warrants to purchase 6,372,530 shares (the "Warrant Shares") of common stock (the "Warrants") at a combined purchase price of $1.02 priced at-the-market under Nasdaq rules. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! |
EBET Announces Approximately $6.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesEBET, Inc. (NASDAQ:EBET), a leading global provider of advanced wagering products and technology, announces today that it has entered into securities purchase agreements (the "Purchase Agreement") with institutional investors for the purchase and sale of (i) 6,372,530 shares (the "Shares") of common stock and (ii) warrants to purchase 6,372,530 shares (the "Warrant Shares") of common stock (the "Warrants") at a combined purchase price of $1.02 in |
EBET Anticipates England vs. France to be Company's Largest Wagered-On Soccer GameEBET, Inc. (Nasdaq: EBET), a leading global provider of advanced wagering products and technology, announced today that it expects the World Cup quarterfinal between England and France to be the company's largest wagered-on soccer game to date. EBET's main brands Karamba and BetTarget are anticipating high volumes of wagering for Saturday's match, with a large percentage of their customer base from England. Customers can wager on more than 30 bets. France is the slight favorite. |